GALLUS BIOPHARMACEUTICALS
Gallus Biopharmaceuticals, LLC, a contract manufacturer, supplies clinical and commercial bulk biologics to the biopharmaceutical industry in the United States and internationally. It also provides process development, analytical development, process validation, cell banking, stability testing, QA/QC, and regulatory support solutions. The company was founded in 2010 and is based in Wellesley, Massachusetts.
GALLUS BIOPHARMACEUTICALS
Industry:
Biotechnology Manufacturing
Founded:
2010-01-01
Address:
St Louis, Missouri, United States
Country:
United States
Website Url:
http://www.gallusbiopharma.com
Total Employee:
1001+
Status:
Closed
Contact:
314-426-5000
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Domain Not Resolving GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads
Founder
Investors List
Ridgemont Equity Partners
Ridgemont Equity Partners investment in Private Equity Round - Gallus BioPharmaceuticals
Official Site Inspections
http://www.gallusbiopharma.com
- Host name: 89.117.158.3
- IP address: 89.117.158.3
- Location: Ukmerge Republic of Lithuania
- Latitude: 55.25
- Longitude: 24.75
- Timezone: Europe/Vilnius
- Postal: 20001
More informations about "Gallus BioPharmaceuticals"
Gallus Biopharmaceuticals - Contract Manufacturer of Mammalian âŠ
Gallus Biopharma is a mammalian cell culture contract development and manufacturing organization (CMO) that offers a unique level of flexibility and strategic appeal to companies âŠSee details»
Gallus BioPharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 314-426-5000 Gallus Biopharmaceuticals, LLC, a contract manufacturer, supplies clinical and commercial bulk âŠSee details»
News - Gallus Biopharma
Nov 19, 2014 (St. Louis, MO, April 29, 2014) â Gallus BioPharmaceuticals, LLC (Gallus), a premier pure-play biologics contract development and manufacturing organization (CMO), and âŠSee details»
Gallus Acquires Laureate â Gallus Biopharma
Oct 1, 2013 (St. Louis, Missouri â October 1, 2013) â Gallus BioPharmaceuticals, LLC (Gallus), a leading biologics contract manufacturing organization (CMO), today announced its âŠSee details»
Gallus BioPharmaceuticals, LLC - CMOCRO - Domain Name
Gallus Biopharma is a mammalian cell culture contract development and manufacturing organization (CMO) that offers a unique level of flexibility and strategic appeal to companies âŠSee details»
Gallus BioPharmaceuticals Information - RocketReach
Biologics Manufacturing, Contract Manufacturing Organization, Biopharmaceutical Manufacturing, Pharmaceutical Development, Drug Substance, Cdmo, Pharmaceutical Services ...See details»
Ridgemont Equity Partners Buys Gallus Biopharmaceuticals
May 19, 2011 About Gallus Biopharmaceuticals: Gallus Biopharmaceuticals is a premier biologics contract manufacturing organization based in St. Louis, MO. Gallus operates an FDA âŠSee details»
Xcellerex® and Gallus BioPharmaceuticals Announce âŠ
May 26, 2011 Gallus Biopharmaceuticals is a premier biologics contract manufacturing organization based in St. Louis, MO. Gallus operates an FDA-approved, commercially-certified âŠSee details»
Gallus Biopharmaceuticals - PitchBook
Information on acquisition, funding, investors, and executives for Gallus Biopharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
How Mark Bamforth took a big chance with Gallus âŠ
Jul 1, 2013 STL Ernst & Young Entrepreneur of the Year Finalist Mark R. Bamforth founder, president and CEO Gallus BioPharmaceuticals, LLC Mark R. Bamforth helped an American âŠSee details»
Gallus Biopharmaceuticals | Scientist.com
Gallusbiopharma.com: Headquarters: St Louis, MO, US Company Type: Small Business (1-10M TTM Revenue) Description ... Get started If your organization has a Scientist.com âŠSee details»
Gallus Biopharmaceuticals, LLC Completes Initial $20 Million
May 24, 2012 Gallus has transformed the site (acquired from Centocor Biologics, LLC in 2011) from a large, world-class pharmaceutical facility to a stand-alone dynamic contract âŠSee details»
Capabilities â Gallus Biopharma
We are pleased to work with Gallus, a very experienced CMO with an extensive background in the cGMP manufacture of antibodies, ranging from early-stage clinical programs to the âŠSee details»
Gallus Bio Pharmaceuticals - Company Info, Employees
View Gallus biopharmaceuticals gallusbiopharma.com location in 4766 laguardia drive, st. louis, missouri, 63134, united states, revenue, industry and description. Find related and similar âŠSee details»
DPx Holdings B.V. Reaches Definitive Agreement to Acquire Gallus ...
DPx Holdings B.V., privately owned by JLL Partners and Royal DSM, is pleased to announce that it has reached a definitive agreement to acquire all shares of Gallus BioPharmaceuticals, LLC, âŠSee details»
Gallus Expands Management Team With Addition Of Claudette âŠ
Feb 11, 2014 Gallus BioPharmaceuticals, LLC (Gallus), a premier pure-play biologics contract manufacturing organization (CMO) announces the appointment of Claudette Kile as Vice âŠSee details»
Partners â Gallus Biopharma
At Gallus, we continually evaluate and employ new technologies and methods to facilitate efficient development of biopharmaceuticals for our clients. By staying in front of the field with cutting âŠSee details»
Gallus Enters Clinical cGMP Manufacturing Agreement with âŠ
Mar 14, 2014 Gallus BioPharmaceuticals (St. Louis, Missouri â February 25, 2014) â Gallus BioPharmaceuticals, LLC (Gallus), a premier pure-play biologics contract manufacturing âŠSee details»
What is Gallus BioPharmaceuticals? Company Culture, Mission, âŠ
See what employees say it's like to work at Gallus BioPharmaceuticals. Salaries, reviews, and more - all posted by employees working at Gallus BioPharmaceuticals.See details»
DPx Holdings B.V. Reaches Definitive Agreement to Acquire Gallus ...
Aug 27, 2014 DPx Holdings B.V. Reaches Definitive Agreement to Acquire Gallus BioPharmaceuticals Durham, N.C. and St. Louis â (August 27, 2014)âDPx Holdings B.V., âŠSee details»